DeepaBangalore(Bangalore Surya)GoturMD

Pulmonology • Houston, TX

Critical Care Medicine

Physician

Join to view full profile

Dr. Gotur is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gotur's full profile

Already have an account?

Office
6565 Fannin Street
Fondren 270
Houston, TX 77030
Phone+1 713-441-3020

Fax+1 713-793-7064

Education & Training

Icahn School of Medicine at Mount SinaiFellowship, Critical Care Medicine, 2006 - 2008
Westchester Medical CenterResidency, Internal Medicine, 2003 - 2006
Bangalore Medical CollegeClass of 2000

Certifications & Licensure

TX State Medical License 2008 - 2026
NY State Medical License 2007 - 2008
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine

Publications & Presentations

PubMed

Clinical impact of pulmonary arterial hypertension on SARS-CoV-2 outcomes: U.S. pre-vaccination analysis.
Omar Tamimi, Chidinma Ejikeme, Tariq Nisar, Deepa Gotur, Zeenat Safdar
Current Problems in Cardiology. 2024-08-01
In adults with post-COVID-19 conditions, a synbiotic preparation, SIM01, alleviated some symptoms at 6 mo.
Deepa Gotur, Eleftherios Mylonakis
Annals of Internal Medicine. 2024-04-01
1 citations
Clinical Outcomes of Heart Transplant Recipients Admitted with COVID-19 Infection in 2020: A Nationwide Analysis.
Omar Tamimi, Faisal Tamimi, Tariq Nisar, Ahmed Osama Gaber, Jiejian Lin
Current Problems in Cardiology. 2023-12-01

Press Mentions

I Mab : Reports Positive Interim Analysis from Phase 2/3 Study of Its GM-CSF Antibody Plonmarlimab (TJM2) to Treat Patients with Severe COVID-19 (Form 6-K)August 16th, 2021
I-mab Reports Positive Interim Analysis from Phase 2/3 Study of Its GM-CSF Antibody Plonmarlimab (TJM2) to Treat Patients with Severe COVID-19August 11th, 2021
Arthritis Drugs ‘Impressive’ for Severe COVID but Not ‘Magic Cure’January 15th, 2021
Join now to see all